As of 2026-09-09, the Fair Value of Medifast Inc (MED) is -11.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.16 USD, the upside of Medifast Inc is -194.67%.
With the market price of 12.16 USD and our fair value calculation, Medifast Inc (MED) is not a good investment. Investing in Medifast stocks now will result in a potential loss of 194.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 164.00 | 143.60 | 99.42 | 2.09 | -18.67 | 78.09 |
| YoY growth | 59.38% | -12.44% | -30.77% | -97.90% | -992.97% | -214.94% |
| Market Cap (mil) | 135.22 |
| P/E | |
| Forward P/E |
| EPS | -2.30 |
| Avg earnings growth rate | -214.94% |
| TTM earnings | -25.60 |